MARASTONI, DAMIANO
 Distribuzione geografica
Continente #
NA - Nord America 2.256
EU - Europa 2.129
AS - Asia 1.659
SA - Sud America 281
AF - Africa 96
OC - Oceania 7
Totale 6.428
Nazione #
US - Stati Uniti d'America 2.169
RU - Federazione Russa 1.072
SG - Singapore 671
CN - Cina 330
IT - Italia 319
BR - Brasile 223
VN - Vietnam 190
GB - Regno Unito 146
HK - Hong Kong 146
DE - Germania 114
FI - Finlandia 92
FR - Francia 84
SE - Svezia 81
IE - Irlanda 70
TR - Turchia 60
CA - Canada 52
KR - Corea 44
BD - Bangladesh 43
ID - Indonesia 35
IN - India 33
NL - Olanda 33
JP - Giappone 23
MX - Messico 23
PL - Polonia 22
AT - Austria 21
EG - Egitto 21
AR - Argentina 18
UA - Ucraina 18
TG - Togo 15
ZA - Sudafrica 15
BJ - Benin 14
ES - Italia 13
IQ - Iraq 13
NG - Nigeria 11
CO - Colombia 10
IR - Iran 10
EC - Ecuador 9
CH - Svizzera 8
UZ - Uzbekistan 7
CL - Cile 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
BE - Belgio 5
PY - Paraguay 5
HR - Croazia 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
RS - Serbia 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
QA - Qatar 2
SC - Seychelles 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 6.421
Città #
Ashburn 389
Moscow 386
Singapore 345
San Jose 267
Chandler 204
Dallas 193
Hong Kong 146
Verona 131
The Dalles 87
Dublin 67
Council Bluffs 64
Beijing 63
Los Angeles 63
New York 59
Southend 59
Ho Chi Minh City 56
Helsinki 52
Istanbul 41
Redmond 39
Munich 36
São Paulo 32
Hanoi 30
London 29
Princeton 29
Jakarta 27
Lappeenranta 27
Montreal 26
Buffalo 24
Jacksonville 23
Lawrence 22
Orem 21
Dong Ket 20
Milan 20
Tokyo 20
Warsaw 20
Santa Clara 19
Redondo Beach 18
Amsterdam 17
Atlanta 16
Sindelfingen 16
Lomé 15
Phoenix 15
Cotonou 14
Columbus 13
Nuremberg 13
Poplar 13
Toronto 13
Wilmington 13
Brooklyn 12
Chicago 12
Frankfurt am Main 12
Haiphong 12
Rome 12
Seattle 12
Tianjin 12
Turku 12
Chennai 11
Falkenstein 11
Jinan 11
Johannesburg 11
Stockholm 11
Woodbridge 11
Abuja 10
Bologna 10
Cairo 10
Houston 10
Mexico City 10
Vienna 10
Ankara 9
Da Nang 9
Denver 9
Guangzhou 9
Ann Arbor 8
Paris 8
Piscataway 8
Washington 8
City of London 7
East Lansing 7
Manchester 7
Redwood City 7
San Francisco 7
Taizhou 7
Baghdad 6
Chirignago 6
Mumbai 6
Nanjing 6
Querétaro 6
Rio de Janeiro 6
Seoul 6
Tashkent 6
Baku 5
Biên Hòa 5
Dhaka 5
Duncan 5
Kyiv 5
Norwalk 5
Porto Alegre 5
Shenyang 5
Taiyuan 5
Zhengzhou 5
Totale 3.742
Nome #
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 221
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 214
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 213
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 204
IMMUNOPATHOLOGY OF INTRATHECAL INFLAMMATION IN MULTIPLE SCLEROSIS: CLINICAL, RADIOLOGICAL AND IMMUNOLOGICAL CORRELATES 192
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 184
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 183
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 170
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 168
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 168
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 166
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 164
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 162
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 161
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 159
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 155
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 153
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 153
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 151
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 148
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 147
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 145
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 142
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 141
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 140
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 133
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 131
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 129
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 128
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 128
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 124
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 122
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 121
Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature 120
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 117
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis 113
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 110
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 108
The effect of air pollution on {COVID}-19 severity in a sample of patients with multiple sclerosis 103
The BAFF / APRIL system as therapeutic target in multiple sclerosis 99
Prominent role of executive functioning on the Phonemic Fluency Test in people with multiple sclerosis 78
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 77
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 73
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 72
Unsupervised Clustering Based on Quantitative Magnetic Resonance Imaging Features Contributes to the Characterization of MS White Matter Lesions 41
Choroid plexus volume predicts progression independent of relapse activity in early relapsing multiple sclerosis 38
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis 33
Quantitative Magnetic resonance imaging lesion features allow machine learning-based classification of MS patients with Progression Independent of Relapse Activity 29
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis 29
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study 27
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes 13
Dynamic emotion recognition and authenticity detection in multiple sclerosis: preliminary cognitive, behavioral, and neuroimaging evidence 12
Totale 6.512
Categoria #
all - tutte 23.477
article - articoli 22.355
book - libri 0
conference - conferenze 761
curatela - curatele 0
other - altro 361
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022217 6 65 0 51 2 1 9 10 5 19 11 38
2022/2023505 33 74 34 93 29 113 5 38 60 3 11 12
2023/2024354 11 20 22 53 29 71 24 13 6 33 58 14
2024/20251.258 55 75 53 212 60 68 85 88 178 76 87 221
2025/20263.932 219 200 221 655 1.061 231 358 211 347 234 88 107
Totale 6.512